コンテンツへスキップ
Merck
  • Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes.

Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes.

Toxicology letters (2014-03-04)
Yanfei Li, Dan Shen, Xiaomei Tang, Xin Li, Da Wo, Hongwei Yan, Rui Song, Jian Feng, Ping Li, Jie Zhang, Jue Li
要旨

Cardiac hypertrophy is an independent risk factor for cardiovascular disease and its subsequent progression to heart failure represents a major cause of morbidity and mortality in the world. CGA is an important component of Chinese herbal medicine, acting as an antioxidant, scavenging free radicals and preventing inflammation. This study found that with the pre-treatment of chlorogenic acid in Iso-induced neonatal rat myocytes, the levels of the hypertrophic markers, ANP, BNP and β-MHC decreased. The nuclear translocation of NF-κB was blocked, whereas NF-κBIA, an inhibitor of NF-κB, was upregulated accordingly. And the level of the intracellular ROS was also reduced. These data reveal that chlorogenic acid may inhibit Iso-induced cardiac hypertrophy by attenuating NF-κB signaling pathway and suppressing ROS.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
クロロゲン酸, ≥95% (titration)
Sigma-Aldrich
イソプレナリン 塩酸塩
クロロゲン酸, primary reference standard
クロロゲン酸, European Pharmacopoeia (EP) Reference Standard
Isoprenaline sulfate, European Pharmacopoeia (EP) Reference Standard
イソプレナリン 塩酸塩, European Pharmacopoeia (EP) Reference Standard